P021
Peptide 021, GLXC-21260
A tetrapeptide derived from CNTF, designed to promote neurogenesis, enhance cognition, and mitigate Alzheimer's pathologies by modulating neurotrophic signaling.
Completed
PHASE3
NCT02151851
A Study of Certolizumab Pegol as Additional Therapy in Chinese Patients With Active Rheumatoid Arthritis
UCB Pharma SA, Belgium
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE4
NCT02365233
Fatty Liver Study in Patients With Type II Diabetes
The University of Texas Medical Branch, Galveston
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE1
NCT01958372
Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer
Barbara Ann Karmanos Cancer Institute
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE4
NCT02688933
A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes Mellitus
Sanofi
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT04064411
Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis
Radius Health, Inc.
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
PHASE2
NCT00931840
A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma
Enzon Pharmaceuticals, Inc.
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE4
NCT01127269
Safety and Effectiveness Study of Insulin Glargine (LANTUS) Initiation and Titration in Patients With Type 2 Diabetes
Sanofi
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT01119105
Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
Nabriva Therapeutics AG
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
PHASE4
NCT02933333
G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE4
NCT02201004
TOFO Insulin Combination Trial
Sanofi
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE4
NCT01117350
Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure
Sanofi
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE1
NCT03520790
Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer
Dana-Farber Cancer Institute
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE4
NCT00673790
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Forest Laboratories
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE3
NCT03907488
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE4
NCT00568542
Chronic, Low Dose Erythropoetin Beta in Ischemic Cardiomyopathy
Charite University, Berlin, Germany
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT01415505
Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 Hypertension
Forest Laboratories
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT02319642
An Open-label Extension Study of Certolizumab Pegol in Chinese Patients With Rheumatoid Arthritis Who Enrolled in RA0044
UCB Pharma SA
INTERVENTIONAL
Updated Dec 15, 2025